We narrowed to 332 results for: aga

...complexes - from the cell-lysate using antibodies against the target protein. The captured protein complexes...

...Another interesting approach is to design screens against known druggable targets, preferentially those for...

...for sufficient opsin to reach the axon terminal. Again, this must be empirically determined in your own...

...precise location. The end of the heteroduplex rests against the RuvC nuclease domain, which stabilizes the ...

... during the reprogramming process as they are propagated in vitro as part of the process. This opens up...

...pick one or the other. Which prime editor is which again? We’re glad you asked. Hopefully this table helps...

...succeed. With respect to de novo sgRNA design, I again separate it into two categories. On the one hand...

...used to protect the RNAs from cellular defenses against ssRNA: phosphatase treatment, substituting cytidine...

... MC, Metzger A, Titus KR, Gilgenast TG, Gong W, Beagan JA, Raj A, Phillips-Cremins JE (2019) LADL: light-activated...

...is taken up on one side of the cell and released again at another side of the cell after intracellular ...

...of your protein-based buffer (FBS, milk, etc.) against the same amount of sample.  If you’re using chemical...

...peptide-peptide interaction to link affibodies or antibodies against common tumor markers to enhance cancer cell capture...